Vimarsana
Biggest News Aggregation in the World

Page 4 - Nextcell Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nextcell Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nextcell Pharma Today - Breaking & Trending Today

Diamyd Medical AB: Updated results from clinical trial with Diamyd presented today at diabetes conference - Vimarsana News

Diamyd Medical AB: Updated results from clinical trial with Diamyd presented today at diabetes conference

STOCKHOLM, Sept. 20, 2022 /PRNewswire/ -- Updated 12-month results from the open-label investigator-initated Phase II clinical trial GADinLADA that assessed three intralymphatic injections of

Diamyd Medical AB: Promising topline results for intralymphatic Diamyd in patients with LADA - Vimarsana News

Diamyd Medical AB: Promising topline results for intralymphatic Diamyd in patients with LADA

STOCKHOLM, July 7, 2022 /PRNewswire/ -- The primary endpoints of safety and tolerability were met in the open-label investigator-initiated Phase II clinical trial GADinLADA, in which the diabetes

Promising topline results for intralymphatic Diamyd® in patients with LADA - Vimarsana News

Promising topline results for intralymphatic Diamyd® in patients with LADA

/PRNewswire/ -- The primary endpoints of safety and tolerability were met in the open-label investigator-initiated Phase II clinical trial GADinLADA, in which...

Diamyd Medical AB: New meta-analysis with Diamyd published in scientific journal - Vimarsana News

Diamyd Medical AB: New meta-analysis with Diamyd published in scientific journal

STOCKHOLM, April 20, 2022 /PRNewswire/ -- An update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes vaccine Diamyd in individuals recently diagnosed with Type

New meta-analysis with Diamyd® published in scientific journal - Vimarsana News

New meta-analysis with Diamyd® published in scientific journal

/PRNewswire/ -- An update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes vaccine Diamyd® in individuals recently diagnosed...